# POLYMYXIN B

NDC: 63323-321
Generic name: POLYMYXIN B SULFATE
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRATHECAL, INTRAVENOUS, OPHTHALMIC
Marketing started: 20091117

FDA application: ANDA065372

## Active ingredients

- POLYMYXIN B SULFATE: 500000 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-321"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-321
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fbc12c18-567b-41bc-89d0-efd29616615c